Pfizer earnings: Looking toward an ambitious 2022 agenda
October 29, 2018 at 10:47 AM EDT
Pfizer plans to have up to 30 new drug approvals in the coming years, to make up for losing patent protection on a number of valuable products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|